Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Missed HPV vaccination opportunities: a consequence of avoiding awkward conversations

In the US, routine administration of quadrivalent HPV vaccine is recommended for girls and boys at 11-12 yrs, with catch-up vaccination recommended up to 26 yrs for girls, and 21 yrs for boys.  The difficulty has been in the implementation of the recommendation: overall rates of initiating and completion among US teenage girls currently stand at 57% and 35% respectively.

Published
11 November 2014
From
BMJ
Misunderstanding of questions regarding anal sex in microbicide HIV prevention trial

There was widespread misunderstanding and misinterpretation of questions about anal sex being asked of participants in the Vaginal and Oral Interventions to Control the Epidemic (VOICE) trial,

Published
10 November 2014
By
Lesley Odendal
Addiction services in England: in need of an intervention

With change comes both opportunity and chaos: an assertion nowhere more true than with England's addiction services. Over the past 5 years, government initiatives to increase cost-effectiveness have opened up bidding for local services to third-party providers. With increased competition, the thinking went, bloated NHS trusts would sharpen their edges and the quality of care would be improved.

Published
10 November 2014
From
The Lancet Psychiatry
Time for the UK to get ready for PrEP

The results of the PROUD study will renew calls for the intervention to be made available in the UK. Further study is needed to confirm the wider acceptability of PrEP to the highest risk individuals and how it affects risk behaviour, but the UK health authorities should begin now to look into how best to deploy this intervention. The numbers show that a new approach to curbing the HIV epidemic in the UK's MSM is needed, the approach exists, and should be made available as soon as possible.

Published
10 November 2014
From
The Lancet HIV
Rupert Whitaker: A pill for risky sex—another step on the road to a pill for bad housing

The primary problem with PrEP is that, firstly, just as with HIV medications and condoms, it would not necessarily be delivered as part of adequate services in the clinic and, secondly, we don’t always use them properly, sometimes for very good reasons. In real life, physicians won’t always be compliant with guidelines that require PrEP to be prescribed as part of even a minimal programme of behavioural health, and this will increase the risk of problems that are already well evidenced with both PrEP and HIV treatment, such as non-adherence and disengagement from services.

Published
08 November 2014
From
BMJ Group Blogs
Learning, Dating and Hooking Up: Sex Education Goes Online in Cambodia

The transition to puberty can be an awkward experience for youth to navigate. In Cambodia, sex education is moving increasingly into the virtual realm, with the Internet and mobile phones providing welcome spaces for young people to learn, seek help and stay safe.

Published
07 November 2014
From
Inter Press Service
Is PARTNER Good News Being Ignored?

Bob Leahy on how Canada has interpreted the preliminary results of the ground-breaking PARTNER study. In some quarters it’s still “wait and see”, but wait and see what? And does “wait and see” cut it with poz gay men?

Published
07 November 2014
From
Positive Lite
Truvada PrEP use rising in United States, especially among men

The number of people using Truvada for pre-exposure prophylaxis (PrEP) in the US is increasing and a growing proportion of users are men, according to an analysis of

Published
07 November 2014
By
Liz Highleyman
Official drug advisers reject time limit on methadone substitution for addicts

Advisory Council on the Misuse of Drugs says time limits advocated by Iain Duncan Smith would lead to high rates of relapse.

Published
06 November 2014
From
The Guardian
D-day for The Pill for HIV

The media coverage of the unexpectedly early success of two trials of pre-exposure prophylaxis - PrEP - has generally been positive, sometimes overly so. But I haven't seen anything that actually explains why the results of the PROUD and IPERGAY studies are so important, or why they represent a gear-change in the accelerating race towards the end of HIV.

Published
05 November 2014
From
Huffington Post

Filter by country